Healthcare & Life Sciences
Prostatype Genomics
Prostatype Genomics is a Healthcare & Life Sciences startup based in Sweden, most recent round Series C+, 3 tracked investors.
activeseries-c-plus
series-c-plus
Stage
3
Investors
About Prostatype Genomics
Prostatype Genomics is a company headquartered in Sweden. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Prostatype Genomics develops and commercializes a prognostic gene test for prostate cancer that helps clinicians and patients make informed treatment decisions by assessing the aggressiveness of the cancer.
Explore Prostatype Genomics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.